First Eagle Investment Management
BRLI

First Eagle Investment Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

First Eagle Investment Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,000
Closed -$332K – 419
2014
Q1 		$332K Hold
12,000
– – ﹤0.01% 270
2013
Q4 		$306K Hold
12,000
– – ﹤0.01% 273
2013
Q3 		$359K Hold
12,000
– – ﹤0.01% 250
2013
Q2 		$345K Buy
+12,000
New +$331K ﹤0.01% 278

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management's BRLI Position: Q2 2014 in Review

First Eagle Investment Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2014, closing a stake of 12,000 shares — an estimated $332K sold.

First Eagle Investment Management first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $359K in Q3 2013. 168 funds tracked by Wall St. Rank hold BRLI as of Q2 2014.

  • First Eagle Investment Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2014 after selling out during the quarter.
  • First Eagle Investment Management sold 12,000 BIO-REFERENCE LABS INC-NEW- shares in Q2 2014, an estimated $332K.
  • First Eagle Investment Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
  • First Eagle Investment Management's BIO-REFERENCE LABS INC-NEW- position peaked at $359K in Q3 2013.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2014.

Based on First Eagle Investment Management's 13F filing for Q2 2014, filed 8 Aug 2014.